Itsara, A., Rogness, V. M., Samples, L., Yuan, C. M., Wang, H., Ahn, I. E., Farooqui, M. Z. H., Tian, X., Sun, C., Tomasulo, E., Soto, S., Superata, J., Bezkorovaynaya, L., Hughes, T. E., Nierman, P., Wiestner, A. (2026). A decade of ibrutinib for CLL with and without
                    <i>TP53</i>
                    aberration: final report on an investigator-sponsored phase 2 study. Blood. https://doi.org/10.1182/blood.2025029971